www.fdanews.com/articles/145614-mylan-launches-first-generic-version-of-lescol-capsules
Mylan Launches First Generic Version of Lescol Capsules
April 13, 2012
Mylan announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration on its ANDA for Fluvastatin Capsules USP, 20 mg and 40 mg, the first generic version of Novartis’ Lescol.
Daily Markets
Daily Markets